Slow Capital’s Pfizer PFE Stock Holding History

Slow Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-47,922	Closed	-$1.76M	–	183
2021 Q1	$1.76M	Sell	47,922 -4,331	-8%	-$154K	0.38%	100
2020 Q4	$1.92M	Sell	52,253 -5,546	-10%	-$203K	0.46%	82
2020 Q3	$2.01M	Sell	57,799 -2,000	-3%	-$70.1K	0.55%	64
2020 Q2	$1.85M	Buy	59,799 +838	+1%	+$28.5K	0.54%	67
2020 Q1	$1.83M	Sell	58,961 -1,633	-3%	-$55.6K	0.69%	47
2019 Q4	$2.25M	Sell	60,594 -92	-0.2%	-$3.28K	0.7%	41
2019 Q3	$2.07M	Sell	60,686 -3,129	-5%	-$114K	0.73%	48
2019 Q2	$2.62M	Buy	63,815 +80	+0.1%	+$3.18K	1.08%	25
2019 Q1	$2.57M	Buy	63,735 +940	+1%	+$37.6K	1.02%	30
2018 Q4	$2.6M	Sell	62,795 -1,441	-2%	-$59.8K	1.25%	18
2018 Q3	$2.69M	Buy	64,236 +959	+2%	+$36.9K	1.2%	23
2018 Q2	$2.18M	Sell	63,277 -1,394	-2%	-$47.6K	1.1%	26
2018 Q1	$2.18M	Buy	64,671 +1,946	+3%	+$66.9K	0.98%	29
2017 Q4	$2.16M	Buy	+62,725	New	+$2.14M	1.12%	31

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Slow Capital's PFE Position: Q2 2021 in Review

Slow Capital sold out of Pfizer (PFE) in Q2 2021, closing a stake of 47,922 shares — an estimated $1.76M sold.

Slow Capital first reported a position in PFE in Q4 2017 and held it in 14 quarters. The position peaked at $2.69M in Q3 2018. 2,732 funds tracked by Wall St. Rank hold PFE as of Q2 2021.

Slow Capital reported no remaining Pfizer position as of Q2 2021 after selling out during the quarter.
Slow Capital sold 47,922 Pfizer shares in Q2 2021, an estimated $1.76M.
Slow Capital first reported a position in Pfizer in Q4 2017 and held it in 14 quarters.
Slow Capital's Pfizer position peaked at $2.69M in Q3 2018.
2,732 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.

Based on Slow Capital's 13F filing for Q2 2021, filed 29 Jul 2021.